Apoptotic signaling by c-MYC

被引:408
作者
Hoffman, B. [1 ]
Liebermann, D. A. [1 ]
机构
[1] Temple Univ, Sch Med, Dept Biochem, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
关键词
c-MYC; apoptosis; Bcl-2; family; mitochondria; death receptors; cancer;
D O I
10.1038/onc.2008.312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-MYC has a pivotal function in growth control, differentiation and apoptosis, and its abnormal expression is associated with many tumors. Overexpression of c-MYC sensitizes cells to apoptosis by a variety of stimuli. The decision of a cell to undergo apoptosis and how this apoptotic response is regulated by c-MYC depends on the specific cell type and the physiological status of the cell. Multiple cooperating molecular pathways of cell survival and apoptosis determine whether a cell lives or dies, and understanding how c-MYC interfaces with these pathways to influence the survival of cells is important to understand normal and abnormal development, tumor initiation and progression, and response of tumors to different treatment regimens. This article will provide an overview of the function of the tumor suppressor gene product p53 in the c-MYC-mediated apoptotic response and how c-MYC amplifies the intrinsic mitochondrial pathway and triggers and/or amplifies the death receptor pathways. Finally, a model for how deregulated c-MYC prematurely triggers the normal apoptotic response associated with terminal myeloid differentiation while also blocking the differentiation program is presented.
引用
收藏
页码:6462 / 6472
页数:11
相关论文
共 91 条
[11]  
ASKEW DS, 1993, BLOOD, V82, P2079
[12]   The Max network gone mad [J].
Baudino, TA ;
Cleveland, JL .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (03) :691-702
[13]   FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf [J].
Bouchard, Caroline ;
Lee, Soyoung ;
Paulus-Hock, Viola ;
Loddenkemper, Christoph ;
Eilers, Martin ;
Schmitt, Clemens A. .
GENES & DEVELOPMENT, 2007, 21 (21) :2775-2787
[14]   Expression of Fas ligand in activated T cells is regulated by c-Myc [J].
Brunner, T ;
Kasibhatla, S ;
Pinkoski, MJ ;
Frutschi, C ;
Yoo, NJ ;
Echeverri, F ;
Mahboubi, A ;
Green, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) :9767-9772
[15]   c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis [J].
Cao, Xuefang ;
Bennett, Richard L. ;
May, W. Stratford .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (21) :14490-14496
[16]   The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1 [J].
Cavarretta, I. T. ;
Neuwirt, H. ;
Untergasser, G. ;
Moser, P. L. ;
Zaki, M. H. ;
Steiner, H. ;
Rumpold, H. ;
Fuchs, D. ;
Hobisch, A. ;
Nemeth, J. A. ;
Culig, Z. .
ONCOGENE, 2007, 26 (20) :2822-2832
[17]   Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: Transrepression correlates with acceleration of apoptosis [J].
Conzen, SD ;
Gottlob, K ;
Kandel, ES ;
Khanduri, P ;
Wagner, AJ ;
O'Leary, M ;
Hay, N .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :6008-6018
[18]   Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damage [J].
Corn, Paul G. ;
El-Deiry, Wafik S. .
CANCER BIOLOGY & THERAPY, 2007, 6 (12) :1858-1866
[19]   The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation [J].
D'Angelo, Santo ;
Liebermann, Dan ;
Hoffman, Barbara .
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 216 (01) :120-127
[20]   The c-Myc target gene network [J].
Dang, Chi V. ;
O'Donnell, Kathryn A. ;
Zeller, Karen I. ;
Nguyen, Tam ;
Osthus, Rebecca C. ;
Li, Feng .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) :253-264